Increasing selective delivery of STAT3 MCs to the tumor as much as possible is of great importance for targeting survival signals and immune checkpoints directly in TNBC cells and indirectly in cancer-associated immunosuppressive cells. This evidence concerns the gene STAT3 and cancer.